The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth
It is well established that Cholangiocarcioma (CCA) drug resistance plays a crucial role in the spread and survival of cancer cells.
Estanislao Peixoto +2 more
exaly +3 more sources
The nicotinamide phosphoribosyltransferase inhibitor FK866 restricts influenza A virus replication by perturbing viral polymerase activity [PDF]
Nicotinamide phosphoribosyltransferase (NAMPT), a key rate-limiting enzyme in NAD+ synthesis, plays important roles in various physiological and pathological processes.
Changjie Lv +5 more
doaj +2 more sources
Inhibiting Nampt signaling promotes M2 macrophage polarization to enhance bone regeneration in periodontitis [PDF]
BackgroundDysregulated macrophage polarization is a fundamental cause of bone loss in periodontitis. However, the role of nicotinamide phosphoribosyltransferase (NAMPT) in macrophage regulation within periodontitis remains unclear.
Yixin Xia +4 more
doaj +2 more sources
Hydrogen Sulfide Protects Against Cerebral Ischemia–Reperfusion Injury in Rats via S-Sulfhydrating NAMPT to Enhance Mitochondrial Function and Autophagy in Cerebrovascular Endothelial Cells [PDF]
Objective: Cerebral ischemia–reperfusion (I/R) injury constitutes a pivotal pathological driver in cerebrovascular disorders such as stroke, yet effective therapeutic interventions remain scarce.
La Jiang +8 more
doaj +2 more sources
Aerobic exercise combined with FK866 ameliorates Alzheimer’s disease-like pathology in APP/PS1 mice with NAMPT abnormality [PDF]
Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the NAD+ salvage pathway, has emerged as an important regulatory node linking metabolic homeostasis to neuroinflammatory responses.
Chang Sun +4 more
doaj +2 more sources
NAMPT activity plays a key role in driving autoimmune processes that mediate beta-cell death and type 1 diabetes development in mice [PDF]
Type 1 diabetes (T1D) is characterised by destruction of pancreatic beta-cells by islet-infiltrating cytotoxic lymphocytes and elevated intra-islet secretion of pro-inflammatory cytokines.
Daniel Egbase +20 more
doaj +3 more sources
RAS/PI3K pathway mutations sensitise epithelial ovarian cancer cells to a PARP/NAMPT inhibitor combination [PDF]
The combination of PARP and NAMPT inhibitors (PARPi/NAMPTi) has been explored for the treatment of triple-negative breast cancer, Ewing sarcoma and high-grade serous carcinoma (HGSC). However, dose limiting toxicity has hampered NAMPTi in clinical trials.
Michael Gruet +18 more
doaj +2 more sources
ROS‐Responsive Hydrogel for Localized Delivery of Nampt and Stat3 Inhibitors Exhibits Synergistic Antitumor Effects in Colorectal Cancer Through Ferroptosis Induction and Immune Microenvironment Remodeling [PDF]
Targeting Nampt to modulate NAD+ metabolism and exert antitumor effects has become a research hotspot in the field of cancer metabolism. But early clinical trials have only achieved modest results, primarily due to the need for improved efficacy and the ...
Chenyang Ye +14 more
doaj +2 more sources
Targeting iNAMPT and NAD Biosynthesis to Break the Obesity-Associated Liver Cancer Link [PDF]
Background and Objectives: Obesity is linked to liver cancer through metabolic mechanisms and can promote tumor growth through metabolic impairment, decreased lipid metabolism, and interference of the energy balance in the liver.
Kelly Thornton +6 more
doaj +2 more sources
The Fluorinated NAD Precursors Enhance FK866 Cytotoxicity by Activating SARM1 in Glioblastoma Cells
Glioblastoma, a formidable brain tumor characterized by dysregulated NAD metabolism, poses a significant therapeutic challenge. The NAMPT inhibitor FK866, which induces NAD depletion, has shown promise in controlling tumor proliferation and modifying the
Yong Juan Zhao, Wanhua Li, Wei Ming He
exaly +3 more sources

